Search

everythinglearnresearchcommunity

for

Search:↓

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

More people were diagnosed with certain skin diseases and sexually transmitted diseases in 2014 compared to 2003 in a Brazilian public institution.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Modern wound dressings like hydrocolloids, alginates, and hydrogels improve healing and are cost-effective.

No clear link between finasteride use and acute pancreatitis risk.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

ECM-inspired wound dressings can help heal chronic wounds by controlling macrophage activity.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Using a patient's own fat tissue helped treat hair loss caused by an injury.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.